NextCure Inc (NXTC)
1.70
+0.05
(+3.03%)
USD |
NASDAQ |
May 17, 16:00
1.70
0.00 (0.00%)
After-Hours: 20:00
NextCure Free Cash Flow: -51.41M for March 31, 2024
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| March 31, 2024 | -51.41M |
| December 31, 2023 | -53.79M |
| September 30, 2023 | -52.92M |
| June 30, 2023 | -55.40M |
| March 31, 2023 | -55.28M |
| December 31, 2022 | -56.00M |
| September 30, 2022 | -60.50M |
| June 30, 2022 | -58.19M |
| March 31, 2022 | -60.72M |
| December 31, 2021 | -59.64M |
| September 30, 2021 | -52.59M |
| Date | Value |
|---|---|
| June 30, 2021 | -56.92M |
| March 31, 2021 | -54.72M |
| December 31, 2020 | -52.09M |
| September 30, 2020 | -55.63M |
| June 30, 2020 | -46.52M |
| March 31, 2020 | -43.02M |
| December 31, 2019 | -38.99M |
| September 30, 2019 | -7.622M |
| June 30, 2019 | -4.21M |
| March 31, 2019 | 2.182M |
| December 31, 2018 | 4.929M |
Free Cash Flow Range, Past 5 Years
-60.72M
Minimum
Mar 2022
-4.21M
Maximum
Jun 2019
-48.81M
Average
-54.26M
Median
Free Cash Flow Benchmarks
| Assertio Holdings Inc | 34.40M |
| DiaMedica Therapeutics Inc | -20.32M |
| Terns Pharmaceuticals Inc | -75.89M |
| NovaBay Pharmaceuticals Inc | -4.524M |
| Palatin Technologies Inc | -33.83M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -12.61M |
| Cash from Investing (Quarterly) | 17.88M |
| Cash from Financing (Quarterly) | 0.001M |
| Free Cash Flow Per Share (Quarterly) | -0.4531 |
| Free Cash Flow Yield | -110.5% |